Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 1 - General processes for the preparation of peptides
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
12/2003
12/16/2003US6663866 Radioiodinated residualizing antibody conjugates are stable in vivo and used for radoioimmunodetection and radioimmunotherapy, carbohydrates and peptides
12/11/2003WO2003102572A2 Mass spectrometry
12/11/2003WO2003102539A2 Automated protein analysis system comprising capillary electrophoresis-tandem mass spectrometry
12/11/2003WO2003102538A2 Combinatorial chemical library ii
12/11/2003WO2003102209A2 Alternatively spliced isoforms of human hmg co-a reductase
12/11/2003WO2003102207A2 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments
12/11/2003WO2003102192A1 Methods of purification of cytochrome p450 proteins and of their crystallizing
12/11/2003WO2003102190A2 Bacterial polypeptides involved in viability
12/11/2003WO2003102189A1 Allergen from mugwort pollen
12/11/2003WO2003102172A1 Methods and compositions for a ubiquitin map
12/11/2003WO2003102132A2 Non-affinity purification of proteins
12/11/2003WO2003102024A1 Combinatorial chemical library i
12/11/2003WO2003102022A1 Use of reagent homologs for comparative proteomics
12/11/2003WO2003102020A2 Carbon nanotube binding peptides
12/11/2003WO2003101592A1 A method of electrophoresis
12/11/2003WO2003101591A1 Separation of molecules
12/11/2003WO2003101577A1 Production of crystalline materials by using high intensity ultrasound
12/11/2003WO2003066669A3 Process for removing protein aggregates and virus from a protein solution
12/11/2003WO2003062462A3 Method for isolating nucleic acids and protein from a single sample
12/11/2003WO2003059876A3 Heterocyclic compounds, combinatorial libraries thereof and methods of selecting drug leads
12/11/2003WO2003050274A3 Process for harvesting crystalline particles from fermentation broth
12/11/2003WO2003040288A3 Isotopically coded affinity markers 3
12/11/2003WO2003027137A3 Trimeric conjugates of peptidic derivative
12/11/2003WO2002098914A3 Mutants of igf binding proteins and methods of production of antagonists thereof
12/11/2003WO2001002075A9 Method for using laser light to control crystal form
12/11/2003US20030229254 Process for the preparation of 3, 3-dimethylbutanal
12/11/2003US20030229212 Using high-performance tangential-flow filtration (HPTFF) to isolate preferential polypeptides such as immunoadhesins; high throughput assay
12/11/2003US20030229210 Process for the preparation of active somatotropin from inclusion bodies
12/11/2003US20030229208 Humanized immunoglobulins
12/11/2003US20030229201 Method comprising introducing one type or two or more types of a functional molecule post-synthetically following introduction of a precursor monomer unit into a peptide nucleic acid oligomer
12/11/2003US20030229200 Useful in treating or preventing obesity
12/11/2003US20030229017 Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same
12/11/2003US20030229013 Drug delivery
12/11/2003US20030229010 Antidiabetic agents; water in oil microemulsion; immobilization
12/11/2003US20030229006 Amphiphilic oligomers
12/11/2003US20030228700 Provides compounds useful as multifunctional labels in proteomics studies; labels are both lysine specific and increase overall sequence coverage obtained in polypeptide mapping by increasing ionization efficiencies
12/11/2003US20030228657 Methods for enhancing the translation and expression of recombinant proteins
12/11/2003US20030228624 Using high-throughput assay to monitor and evaluate ligand binding; drug screening and design
12/11/2003US20030228605 Identification of protein binding sites
12/11/2003US20030228371 Anti-infarction molecules
12/11/2003US20030228275 Immobilization of drugs
12/11/2003US20030228274 Immobilization of polypeptide with polyamide-polyether
12/11/2003US20030228239 Deactivation using high pressure pulsation; adiabatic heating; food processing
12/11/2003US20030226752 Adjust concentration of sample; electrophoresis gradients
12/11/2003CA2487915A1 Allergen from mugwort pollen
12/11/2003CA2485199A1 Production of crystalline materials by using high intensity ultrasound
12/11/2003CA2478925A1 Non-affinity purification of proteins
12/10/2003EP1369483A1 Allergen from mugwort pollen
12/10/2003EP1368372A2 Peptides having affinity for the gp120 viral protein and use thereof
12/10/2003EP1368370A2 Method of isolating charged compounds, especially peptides and proteins
12/10/2003EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/10/2003EP0771146B1 Fibrin(ogen) degradation and clot lysis by fibrinolytic matrix metalloproteinase
12/10/2003EP0724641B1 Anti-microbial proteins
12/10/2003EP0502892B1 THE HUMAN C3b/C4b RECEPTOR (CR1)
12/10/2003CN1130373C Process for preparing [3'-deoxy-3'oxox-MeBmt] cyclosporin
12/10/2003CN1130372C 肽衍生物 Peptide derivatives
12/09/2003US6660836 Methods for carbon-centered radical mediated heavy hydrogen labeling of compounds
12/09/2003US6660473 C-terminal protein tagging
12/09/2003US6660275 Amplification nucleic acids
12/09/2003US6660234 Generation of preferential nucleotide sequences on preferential substrate; obtain substrate, expose to activator, remove terminal groups, recover biopolymer
12/04/2003WO2003100082A2 Methods of determining precise herg interactions and altering compounds based on said interactions
12/04/2003WO2003100080A2 Capture, concentration and quantitation of abnormal prion protein from biological fluids using depth filtration
12/04/2003WO2003100048A1 Method for the purification of microbial protease
12/04/2003WO2003100042A1 Method for assembling sub units into capsoides
12/04/2003WO2003100015A2 Polypeptide cleavage process
12/04/2003WO2003099855A1 Device for the presentation of peptides or proteins, method for the preparation and use thereof
12/04/2003WO2003099853A2 Petide amidation process
12/04/2003WO2003099852A2 Peptide derivatization process
12/04/2003WO2003099843A2 Peptide derivatives, and their use for the synthesis of silicon-based composite materials
12/04/2003WO2003076936A9 Method of preparing a protein array based on biochemical protein-protein interaction
12/04/2003WO2003050540A3 Flexible method and apparatus for high throughput production and purification of multiple proteins
12/04/2003WO2003045980A3 Glycopeptide remodeling using amidases
12/04/2003WO2003026590A3 Biological control of nanoparticles
12/04/2003WO2002102310A3 Proteins associated with cell growth, differentiation, and death
12/04/2003WO2002090923A3 Methods for assembling protein microarrays
12/04/2003WO2001072771A3 Insulin and igf-1 receptor agonists and antagonists
12/04/2003US20030224967 Use of mass spectrometry to analyze peptides and amino acids in the field of proteomics
12/04/2003US20030224461 Nucleic acids, proteins, and antibodies
12/04/2003US20030224453 Structural models for cytoplasmic domains of transmembrane receptors
12/04/2003US20030224052 Water soluble proteins (especially hair) and covalent interprotein crosslinks other than disulfide crosslinks.
12/04/2003US20030223977 Novel small proteins which bind cathepsin G have been identified. These are useful as inhibitors of excessive cathepsin G activity in patients.
12/04/2003US20030223973 Discloses the protease stratum corneum chymotrytic enzyme (SCCE) is specifically over-expressed in ovarian and other malignancies. A number of SCCE peptides can induce immune responses to SCCE, thereby demonstrating the potential of
12/04/2003US20030221963 Method of electrophoresis
12/04/2003CA2487283A1 Method for assembling sub units into capsoides
12/04/2003CA2486193A1 Methods of determining precise herg interactions and altering compounds based on said interactions
12/04/2003CA2485737A1 Polypeptide cleavage process
12/04/2003CA2485169A1 Peptide derivatives, and their use for the synthesis of silicon-based composite materials
12/03/2003EP1367137A1 Methods of isolating biological target materials using silica magnetic particles
12/03/2003EP1366165A2 G-protein coupled receptors
12/03/2003EP1366078A2 Ige receptor antagonists
12/03/2003EP1366066A2 Cyclohexapeptide having antimicrobial activity
12/03/2003EP1366065A1 Echinocandin derivatives, pharmaceutical compositions containing same and use thereof as drugs
12/03/2003EP1366062A2 Efficient recovery of correctly refolded proteins
12/03/2003EP1366060A2 Methods of purification and recovery of interferon-beta
12/03/2003EP1366017A2 Non-natural basic amino acids, their preparation and use
12/03/2003EP1365813A2 Ascorbic acid analogs for metalloradiopharmaceuticals
12/03/2003CN1460110A Silicatein-mediated synthesis of amorphous silicates and siloxanes and use thereof
12/03/2003CN1459506A Recombination expression and application of Chinese prawn antibacterial peptide gene
12/03/2003CN1459505A Chinese Han nationality people stroma metallopankrin-9 gene reconstitution, expression, purification and its medical application
12/03/2003CN1129609C Flocculation clarification ultrafiltration concentration process of producing composite immunoreactive protein
1 ... 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 ... 518